Sec. 1140. STUDY ON DRUG LABELING BY ELECTRONIC MEANS
118 words·~1 min read·
/statute-compilations/comps-9932/sec-1140A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 1140 STUDY ON DRUG LABELING BY ELECTRONIC MEANS ###
(a)Study The Comptroller General of the United States shall conduct a study on the benefits and efficiencies of electronic patient labeling of prescription drugs, as a complete or partial substitute for patient labeling in paper form. The study shall address the implementation costs to the different levels of the distribution system, logistical barriers to utilizing a system of electronic patient labeling, and any anticipated public health impact of movement to electronic labeling. ###
(b)Report Not later than 1 year after the date of enactment of this Act, the Comptroller General shall submit to Congress a report on the results of the study under subsection (a).